MHRA’s 2030 strategy puts AI on the medicines-regulation agenda
The UK medicines regulator says AI will help shape how it handles evidence and regulation, with an AI Medicines Development Action Plan due next year. Its wider strategy also promises faster regulatory decisions, including halving the targe
Open discussion →